(Q36495570)

14 August 2017

1 reference

title

Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor (English)

1 reference

14 August 2017

5 Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor (English)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80097-7

26 October 2022

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80097-7

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80097-7

26 October 2022

3

C. B. Nemeroff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674857

26 October 2022

author name string

P. M. Doraiswamy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674857

26 October 2022

K. R. Krishnan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674857

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1674857

26 October 2022

publication date

1 March 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:S0950351X05800977?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80097-7

https://api.elsevier.com/content/article/PII:S0950351X05800977?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80097-7

Bailliere's clinical endocrinology and metabolism

26 October 2022

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

59-77

1 reference

Neuropeptides in neurological disease

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Brain-decarboxylase activities as indices of pathological change in senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

GHRH-induced GH response in patients with senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Distribution of corticotropin-releasing factor-like immunoreactivity in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

CRH defects in Alzheimer's and other neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Neuropeptides and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

1 reference

7 January 2021

Depression in early-onset Alzheimer's disease: clinical and neuroendocrine correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Spinal fluid CRF reduction in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Neuropeptides in Alzheimer's disease: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Growth hormone response to growth hormone releasing factor in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Active clearance of corticotropin-releasing factor from the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Neuropeptide coexistence in human cortical neurones.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Parkinson's disease and Alzheimer's disease: new neurochemical parallels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980097-7

7 January 2021

Identifiers

1 reference

release_tpvugh3ycrfhzcqyxzfkfwxnzi

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tpvugh3ycrfhzcqyxzfkfwxnzi

24 November 2022

mapped directly with Wikidata item

1 reference